• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Development of Complex Renal Cysts during Crizotinib Treatment and Also during Alectinib Treatment: A Possible Drug Class Effect?

作者信息

Longo Vito, Catino Anna Maria, Montrone Michele, Pesola Francesco, Pizzutilo Pamela, Delbene Gabriela, Gatti Pietro, Ferrante Annunziata, Galetta Domenico

机构信息

Medical Thoracic Oncology Unit, Scientific Research and Treatment Institute Giovanni Paolo II, Bari, Italy.

Medical Thoracic Oncology Unit, Scientific Research and Treatment Institute Giovanni Paolo II, Bari, Italy.

出版信息

J Thorac Oncol. 2019 Aug;14(8):e170-e172. doi: 10.1016/j.jtho.2019.03.010.

DOI:10.1016/j.jtho.2019.03.010
PMID:31345340
Abstract
摘要

相似文献

1
Development of Complex Renal Cysts during Crizotinib Treatment and Also during Alectinib Treatment: A Possible Drug Class Effect?克唑替尼治疗期间以及阿来替尼治疗期间复杂肾囊肿的发生：一种可能的药物类别效应？
J Thorac Oncol. 2019 Aug;14(8):e170-e172. doi: 10.1016/j.jtho.2019.03.010.
2
Regression of Crizotinib-Associated Complex Cystic Lesions after Switching to Alectinib.换用阿来替尼后克唑替尼相关复杂囊性病变的消退
Intern Med. 2017 Sep 1;56(17):2321-2324. doi: 10.2169/internalmedicine.8445-16. Epub 2017 Aug 10.
3
A Complex Renal Cyst in a Patient on Crizotinib: Case Report.一名服用克唑替尼患者的复杂性肾囊肿：病例报告
Urology. 2019 Sep;131:21-23. doi: 10.1016/j.urology.2019.04.035. Epub 2019 May 9.
4
Renal Injury during Long-Term Crizotinib Therapy.长期克唑替尼治疗期间的肾损伤。
Int J Mol Sci. 2018 Sep 25;19(10):2902. doi: 10.3390/ijms19102902.
5
Efficacy and Safety of ALK Tyrosine Kinase Inhibitors in Elderly Patients with Advanced ALK-Positive Non-Small Cell Lung Cancer: Findings from the Real-Life Cohort.ALK 酪氨酸激酶抑制剂在晚期 ALK 阳性非小细胞肺癌老年患者中的疗效和安全性：真实世界队列研究的结果。
Oncol Res Treat. 2019;42(5):275-282. doi: 10.1159/000499086. Epub 2019 Apr 5.
6
[A case of crizotinib-associated renal cysts].[一例克唑替尼相关的肾囊肿病例]
Zhonghua Jie He He Hu Xi Za Zhi. 2024 Apr 12;47(4):356-359. doi: 10.3760/cma.j.cn112147-20230721-00022.
7
Alectinib versus crizotinib in patients with ALK-positive non-small-cell lung cancer (J-ALEX): an open-label, randomised phase 3 trial.阿来替尼对比克唑替尼用于治疗 ALK 阳性非小细胞肺癌患者（J-ALEX）：一项开放标签、随机、III 期临床试验。
Lancet. 2017 Jul 1;390(10089):29-39. doi: 10.1016/S0140-6736(17)30565-2. Epub 2017 May 10.
8
Alectinib shows CNS efficacy in ALK-positive NSCLC.阿来替尼在ALK阳性非小细胞肺癌中显示出中枢神经系统疗效。
Lancet Oncol. 2018 Oct;19(10):e520. doi: 10.1016/S1470-2045(18)30707-1. Epub 2018 Sep 21.
9
Alectinib versus Crizotinib in Untreated ALK-Positive Non-Small-Cell Lung Cancer.阿来替尼对比克唑替尼用于未经治疗的 ALK 阳性非小细胞肺癌。
N Engl J Med. 2017 Aug 31;377(9):829-838. doi: 10.1056/NEJMoa1704795. Epub 2017 Jun 6.
10
Crizotinib-associated Renal Cyst Formation in a Pediatric Patient With ALK+ Epithelioid Inflammatory Myofibroblastic Sarcoma.克唑替尼相关肾囊肿形成于 1 例 ALK+上皮样炎性肌纤维母细胞瘤的儿科患者。
Urology. 2021 Mar;149:222-224. doi: 10.1016/j.urology.2020.08.032. Epub 2020 Sep 1.

引用本文的文献

1
RET rearrangement as a mechanism of resistance to ALK-TKI in non-small cell lung cancer patient with EML4-ALK fusion: A case report.非小细胞肺癌患者中RET重排作为对EML4-ALK融合型ALK-TKI耐药机制的病例报告
Heliyon. 2024 Apr 22;10(9):e29928. doi: 10.1016/j.heliyon.2024.e29928. eCollection 2024 May 15.
2
Nephrotoxicity of cancer therapeutic drugs: Focusing on novel agents.癌症治疗药物的肾毒性：聚焦新型药物。
Kidney Res Clin Pract. 2021 Sep;40(3):344-354. doi: 10.23876/j.krcp.21.037. Epub 2021 Jul 8.
3
Crizotinib-associated renal cyst development may be associated with prolonged progression-free survival in patients with -positive non-small-cell lung cancer: Case report and review of the literature.
克唑替尼相关肾囊肿的发生可能与ALK阳性非小细胞肺癌患者无进展生存期延长有关：病例报告及文献综述
Clin Case Rep. 2021 Jun 10;9(6):e04278. doi: 10.1002/ccr3.4278. eCollection 2021 Jun.